NCT00906217

Brief Summary

This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2009

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 21, 2009

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2011

Completed
Last Updated

April 3, 2024

Status Verified

April 1, 2024

Enrollment Period

1.5 years

First QC Date

May 19, 2009

Last Update Submit

April 2, 2024

Conditions

Colon Cleansing

Keywords

colonoscopypreparationsafetyelderly

Outcome Measures

Primary Outcomes (1)

  • serum electrolyte changes pre and post preparation

    2 months

Study Arms (1)

elderly patients

patients older than 70 years with normal renal function

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients older than 70 scheduled for colonoscopy

You may qualify if:

  • \>70 years

You may not qualify if:

  • renal dysfunction
  • congestive heart failure
  • ileus

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Lawrence Hookey, MD

    Queen's University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant professor of medicine

Study Record Dates

First Submitted

May 19, 2009

First Posted

May 21, 2009

Study Start

January 1, 2009

Primary Completion

July 1, 2010

Study Completion

September 1, 2011

Last Updated

April 3, 2024

Record last verified: 2024-04